This announcement is a separate document:
大参林：2020年大参林医药集团股份有限公司可转换公司债券2022年跟踪评级报告
Dashenlin: 2020 Dashenlin Pharmaceutical Group Co., Ltd. Convertible Corporate Bonds 2022 Tracking Rating Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.